Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Meriones unguiculatus skin is a diagnostic allergenic extract derived from the skin or pelt of the Mongolian gerbil (*Meriones unguiculatus*). It is primarily utilized as a diagnostic tool for identifying allergic sensitivities to gerbil dander or skin proteins. The product is typically formulated as a solution for subcutaneous injection or skin prick testing, often at a concentration of 0.05 g/mL. As a diagnostic allergen, it works by eliciting a localized hypersensitivity reaction in sensitized individuals, allowing for the clinical assessment of pet-related allergies. Upon administration, the extract's proteins cross-link allergen-specific IgE antibodies on the surface of mast cells and basophils, triggering the release of histamine and other mediators that produce a visible wheal-and-flare reaction.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on meriones unguiculatus skin.